General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

ThinkKidneysOctober 21 2015

Training material on acute kidney injury (AKI) has been sent out to pharmacists as part of the Centre for Pharmacy Postgraduate Education’s autumn campaign.

CPPE has teamed up with the UK Renal Registry and its Think Kidneys programme to highlight the risks of acute kidney injury and to encourage pharmacy professionals to think about how they can help prevent AKI.

The subject matter has been selected as it is “an insidious and life-threatening condition” that pharmacists and other pharmacy professionals in every sector can help prevent, said the CPPE.
It has sent out a distance learning pack on AKI, along with a ‘Think Kidneys’ leaflet and a campaign leaflet.

This contains six challenges for pharmacists:

  • to watch the CPPR ‘Think kidney, talk kidney’ animation
  • to take an online test about AKI
  • to learn and engage with a twitter chat
  • to discuss AKI with the pharmacy team
  • to promote learning about AKI in the pharmacy
  • to pledge to do something that will make a difference to people at risk of developing AKI.

“Let us know how you’re getting involved in the campaign by posting your messages and photos on Facebook and Twitter, using the hashtags #CPPEAKI and #thinkkidneys,” said the CPPE’s Geraldine Flavell and Matthew Shaw.

Think Kidneys is an NHS campaign programme for tackling acute kidney injury. It aims to reduce avoidable harm and death for people with acute kidney injury, and to improve care for patients whether in hospital or at home. The Think Kidney website includes case studies and resources as well as news and blogs and a forum for anyone interested in AKI.

ThinkKidneys2The website also has information about the Sick Day rules’. This is the notion that health professionals should advise patients at increased risk of AKI, such as those with chronic kidney disease, heart failure or if taking certain medications, to temporarily stop taking certain drugs during an acute illness.

An interim position statement published in the summer says that acute illnesses which result in a disturbed fluid balance are particularly relevant, for example due to vomiting or diarrhoea or if there is fever, sweats and shaking.

Drug classes where caution should be taken, include:

  • nonsteroidal anti-inflamatory drugs (NSAIDs)
  • drugs which lower blood pressure or decrease volume - such as ACE inhibitors, angiotensin receptor blockers (ARBs), diuretics, and other anti-hypertensives
  • drugs which may accumulate as a result of reduced kidney function, such as metformin, sulfonylureas and trimethoprim.

Links:

CPPE announcement

CPPE AKI learning campaign

Think Kidneys website

CPPE AKI six challenges leaflet

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...